Santosh Tiwari And Joe C Mathew

Stories by Santosh Tiwari And Joe C Mathew

EC to get tough on norms

EC to get tough on norms

Rediff.com   10 Feb 2011

Election Commission is considering an overhaul of the accounting practices of parties.

ICAI seeks info from Sebi, Reliance Infra

ICAI seeks info from Sebi, Reliance Infra

Rediff.com   10 Feb 2011

The letters were meant to assess if there had been any professional misconduct by any auditors of Reliance Infra and Reliance National Resources Ltd that led to the alleged misrepresentation of investments by these companies.

2G scam cases up for further investigation

2G scam cases up for further investigation

Rediff.com   9 Feb 2011

The ministry of corporate affairs - under new minister Murli Deora - has reopened for further investigation the cases of two companies allegedly involved in the unravelling 2G scam. A senior official said that the ministry was currently probing Swan Telecom and Loop Telecom.

Datacom under CBI lens

Datacom under CBI lens

Rediff.com   8 Feb 2011

The Central Bureau of Investigation (CBI) is looking into the funding and transactions of Datacom Services (now Videocon Mobile), which was among the firms awarded a 2G telecom licence in January 2008.

Daiichi shifts 6 early drug programmes to India

Daiichi shifts 6 early drug programmes to India

Rediff.com   7 Feb 2011

Daiichi Sankyo, Japan's third-largest drug maker, has transferred six of its early drug discovery programmes in inflammatory and infectious diseases from its Japanese research & development (R&D) facilities to India.

Measures to deepen corporate bond market

Measures to deepen corporate bond market

Rediff.com   4 Feb 2011

Budget 2011-12 is likely to announce significant measures to deepen the corporate bond market. Among the several measures on the government's agenda is allowing banks to provide guarantees for bonds issued by companies.

I-T harassment? Solutions soon

I-T harassment? Solutions soon

Rediff.com   27 Jan 2011

Central Board of Direct Taxes chairman Sudhir Chandra told Business Standard that the changes have been approved in principle and necessary instructions would be issued soon.

Data exclusivity still key hurdle to India-EU FTA

Data exclusivity still key hurdle to India-EU FTA

Rediff.com   27 Jan 2011

Despite all official assurances, the path towards a free trade agreement (FTA) between India and the European Union (EU) this year remains ambiguous, as both sides are unwilling to relax their stand on the biggest stumbling block - the issue of "data exclusivity".

Exporters seek more time to carry barcodes

Exporters seek more time to carry barcodes

Rediff.com   18 Jan 2011

The domestic drug industry has expressed serious concern over the central government's decision to make it mandatory to carry a barcode on every medicine pack meant for exports from July 1.

Price rise: PM wants action plan from top advisors

Price rise: PM wants action plan from top advisors

Rediff.com   12 Jan 2011

Prime Minister Manmohan Singh on Tuesday asked his economy A-team to make a concerted effort to tackle rising food prices.

Company secys of Swan, Loop pulled up on 2G report

Company secys of Swan, Loop pulled up on 2G report

Rediff.com   13 Dec 2010

The Institute of Company Secretaries of India (ICSI) has pulled up the company secretaries of two telecom companies whose names have been mentioned in the Comptroller and Auditor General's (CAG's) report on the controversial allotment of airwaves. The two officials named in the report are Hari Nair, representing Swan Telecom, and Vidyadhar Chakradeo, the company secretary of Loop Telecom.

Pharma companies line up for clinical trials

Pharma companies line up for clinical trials

Rediff.com   10 Dec 2010

The numbers are the highest ever in the history of domestic drug discovery initiatives triggered by companies such as Dr Reddy's and Ranbaxy over a decade ago.

R&D firms should compensate trial injuries: DCGI

R&D firms should compensate trial injuries: DCGI

Rediff.com   7 Dec 2010

The Drugs Controller General of India, the apex drug regulator, has included a new clause in the trial approval letters, making these firms also accountable for any possible adverse event.

Three controversial drugs may be banned

Three controversial drugs may be banned

Rediff.com   25 Nov 2010

The Central Drugs Standard Control Organisation (CDSCO), the apex drug regulator, may soon ban the production and sale of three medicines in the country. The drugs - cisapride, phenylpropanolamine (PPA) and human placenta extracts - have been controversial medicines for their alleged adverse reactions for several years now.

Price control on 50% of domestic drugs likely

Price control on 50% of domestic drugs likely

Rediff.com   24 Nov 2010

The eight-member expert committee, which is in charge of revising NLEM, plans inclusion of new drugs to the list and also do away with the current practice of including only specific strengths of medicines in NLEM.

Godrej talking to Israeli firms for dairy foray

Godrej talking to Israeli firms for dairy foray

Rediff.com   23 Nov 2010

Godrej Agrovet Ltd, the agri-business arm of leading conglomerate Godrej Ltd, plans to enter the dairy farming business. The company is in talks with at least two leading Israeli dairy farm technology providers.

NPPA finds huge gap in cancer drug prices

NPPA finds huge gap in cancer drug prices

Rediff.com   1 Nov 2010

The first-ever study conducted by the National Pharmaceutical Pricing Authority (NPPA) on cancer medicines has found huge price variations among different brands of same medicines sold in the country.

Govt yet to decide CWG probe panel members

Govt yet to decide CWG probe panel members

Rediff.com   24 Oct 2010

The structure and the exact mandate of the high-level committee set up to probe the alleged financial irregularities related to the conduct of the Commonwealth Games 2010 remain unclear even a week after the setting up of the panel was announced.

Panel may clear cervical cancer vaccine trials

Panel may clear cervical cancer vaccine trials

Rediff.com   28 Sep 2010

The studies, independently initiated by international non-governmental-organization PATH and Indian Council of Medical Research for GSK and Merck vaccines respectively, were called off early this year after six deaths were reported among the girls who were administered these vaccines in Gujarat and Andhra Pradesh.

Foreign firms call the shots in many insurance JVs

Foreign firms call the shots in many insurance JVs

Rediff.com   28 Sep 2010

Several international insurance firms that operate in India through joint ventures exercise control over them, despite having only a 26 per cent stake. This is the maximum permissible foreign investment.